The epidemiology of carbapenemases in Latin America and the Caribbean

Vista sencilla de ítem
dc.contributor.authorEscandón-Vargas, Kevin
dc.contributor.authorReyes, Sergio
dc.contributor.authorGUTIÉRREZ, SERGIO
dc.contributor.authorVillegas, María Virginia
dc.contributor.orcidVillegas, María Virginia [0000-0003-1898-9067]
dc.date.accessioned2020-07-15T21:36:47Z
dc.date.available2020-07-15T21:36:47Z
dc.description.abstractenglishIntroduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. infections are major causes of morbidity and mortality, especially due to the emergence and spread of β-lactamases. Carbapenemases, which are β-lactamases with the capacity to hydrolyze or inactivate carbapenems, have become a serious concern as they have the largest hydrolytic spectrum and therefore limit the utility of most β-lactam antibiotics. Areas covered: Here, we present an update of the current status of carbapenemases in Latin America and the Caribbean. Expert commentary: The increased frequency of reports on carbapenemases in Latin America and the Caribbean shows that they have successfully spread and have even become endemic in some countries. Countries such as Brazil, Colombia, Argentina, and Mexico account for the majority of these reports. Early suspicion and detection along with implementation of antimicrobial stewardship programs in all healthcare settings are crucial for the control and prevention of carbapenemase-producing bacteria.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1080/14787210.2017.1268918
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1744-8336
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/3506
dc.language.isoeng
dc.publisherTaylor & Francisspa
dc.publisher.journalExpert review of anti-infective therapyspa
dc.relation.ispartofseriesExpert review of anti-infective therapy, 1744-8336, Vol. 15, Nro. 3, 2017, p. 277-297spa
dc.relation.urihttps://www.tandfonline.com/doi/abs/10.1080/14787210.2017.1268918
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2016-12-20
dc.rights.localAcceso abiertospa
dc.subject.decsPseudomonas aeruginosaspa
dc.subject.decsAcinetobacter baumanniispa
dc.subject.decsFarmacorresistencia bacterianaspa
dc.subject.keywordsCarbapenemases, β-lactamasesspa
dc.subject.keywordsCarbapenemsspa
dc.subject.keywordsEnterobacteriaceaespa
dc.titleThe epidemiology of carbapenemases in Latin America and the Caribbeanspa
dc.title.translatedThe epidemiology of carbapenemases in Latin America and the Caribbeanspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos